NAVLIN Insights

NAVLIN Insights offers a comprehensive digital platform and policy tracker that consolidates all market access metrics, insights, and progress into a single, real-time view. This eliminates data silos, manual reporting, and communication gaps, allowing for a clear demonstration of a portfolio’s commercial impact.

Designed specifically for senior pharmaceutical leaders, NAVLIN Insights facilitates faster, insight-driven decisions to optimize pricing and access strategies on a global scale. The platform includes a newly launched policy tracker that provides timely updates on critical topics such as MFN, aiding in informed launch strategies.

Key features include:

• 100% coverage of pricing and HTA benchmarks
• Weekly MFN Intelligence Reports with frequent updates on the U.S. policy environment
• Competitive Intelligence and Executive Dashboards
• Real-Time Market Access Intelligence
• ESG/Equitable Pricing Indices

NAVLIN Insights is customizable to meet specific objectives across all core biopharmaceutical business areas. The platform is supported by a dedicated research team with extensive experience across various disease categories, value propositions, and market access strategies.

It offers speed and efficiency with solutions tailored to specific needs and access to self-service tools for quick answers. Beyond data, NAVLIN Insights provides actionable and credible insights to either confirm current strategies or guide new directions confidently.

For more detailed information, users can download the KPI tracker brochure or connect with the team of experts via email, live chat, or scheduled meetings.